A detailed history of Td Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Td Asset Management Inc holds 1,325,805 shares of AZN stock, worth $86.6 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,325,805
Previous 1,506,428 11.99%
Holding current value
$86.6 Million
Previous $117 Million 12.07%
% of portfolio
0.1%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$76.67 - $87.62 $13.8 Million - $15.8 Million
-180,623 Reduced 11.99%
1,325,805 $103 Million
Q2 2024

Aug 02, 2024

SELL
$66.81 - $80.83 $2.07 Million - $2.5 Million
-30,982 Reduced 2.02%
1,506,428 $117 Million
Q1 2024

May 08, 2024

BUY
$61.03 - $69.57 $7.44 Million - $8.48 Million
121,876 Added 8.61%
1,537,410 $104 Million
Q4 2023

Feb 12, 2024

SELL
$61.89 - $69.28 $30.4 Million - $34 Million
-491,359 Reduced 25.77%
1,415,534 $95.3 Million
Q3 2023

Oct 27, 2023

BUY
$64.85 - $71.7 $33.8 Million - $37.4 Million
521,503 Added 37.64%
1,906,893 $129 Million
Q2 2023

Aug 09, 2023

SELL
$69.91 - $75.81 $10.2 Million - $11 Million
-145,579 Reduced 9.51%
1,385,390 $99.2 Million
Q1 2023

May 10, 2023

SELL
$63.15 - $71.6 $5.49 Million - $6.23 Million
-86,977 Reduced 5.38%
1,530,969 $106 Million
Q4 2022

Feb 06, 2023

SELL
$54.21 - $70.44 $39.2 Million - $51 Million
-723,573 Reduced 30.9%
1,617,946 $110 Million
Q3 2022

Nov 07, 2022

BUY
$53.02 - $135.75 $15.7 Million - $40.1 Million
295,637 Added 14.45%
2,341,519 $129 Million
Q2 2022

Aug 04, 2022

BUY
$59.26 - $71.14 $22.5 Million - $27 Million
379,110 Added 22.75%
2,045,882 $135 Million
Q1 2022

May 10, 2022

BUY
$55.72 - $67.12 $998,112 - $1.2 Million
17,913 Added 1.09%
1,666,772 $111 Million
Q4 2021

Feb 10, 2022

BUY
$54.02 - $63.83 $28.7 Million - $33.9 Million
530,595 Added 47.45%
1,648,859 $96 Million
Q3 2021

Nov 09, 2021

BUY
$55.56 - $60.79 $7.12 Million - $7.79 Million
128,173 Added 12.95%
1,118,264 $67.2 Million
Q2 2021

Aug 11, 2021

BUY
$48.42 - $60.18 $9.01 Million - $11.2 Million
186,086 Added 23.14%
990,091 $56.7 Million
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $10.6 Million - $12.3 Million
225,217 Added 38.91%
804,005 $40 Million
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $1.03 Million - $1.23 Million
21,226 Added 3.81%
578,788 $28.9 Million
Q3 2020

Nov 10, 2020

SELL
$53.07 - $61.1 $1.32 Million - $1.52 Million
-24,929 Reduced 4.28%
557,562 $30.6 Million
Q2 2020

Aug 13, 2020

BUY
$43.1 - $55.31 $2.76 Million - $3.55 Million
64,132 Added 12.37%
582,491 $30.8 Million
Q1 2020

May 15, 2020

BUY
$37.79 - $51.33 $741,326 - $1.01 Million
19,617 Added 3.93%
518,359 $23.2 Million
Q4 2019

Feb 11, 2020

SELL
$42.46 - $50.46 $2.69 Million - $3.19 Million
-63,294 Reduced 11.26%
498,742 $24.9 Million
Q3 2019

Nov 07, 2019

SELL
$40.12 - $45.47 $5.72 Million - $6.48 Million
-142,577 Reduced 20.23%
562,036 $25.1 Million
Q2 2019

Aug 01, 2019

SELL
$37.28 - $41.68 $2.21 Million - $2.47 Million
-59,356 Reduced 7.77%
704,613 $29.1 Million
Q1 2019

May 08, 2019

SELL
$35.49 - $43.02 $3.25 Million - $3.94 Million
-91,514 Reduced 10.7%
763,969 $30.9 Million
Q4 2018

Feb 01, 2019

SELL
$36.86 - $41.49 $5.2 Million - $5.86 Million
-141,129 Reduced 14.16%
855,483 $32.5 Million
Q3 2018

Nov 01, 2018

SELL
$34.76 - $39.72 $2.35 Million - $2.69 Million
-67,649 Reduced 6.36%
996,612 $39.4 Million
Q2 2018

Jul 31, 2018

BUY
$34.55 - $37.05 $185,049 - $198,439
5,356 Added 0.51%
1,064,261 $37.4 Million
Q1 2018

May 11, 2018

BUY
$32.97 - $36.63 $161,421 - $179,340
4,896 Added 0.46%
1,058,905 $37 Million
Q4 2017

Feb 02, 2018

BUY
$32.09 - $34.78 $4.9 Million - $5.31 Million
152,731 Added 16.95%
1,054,009 $36.6 Million
Q3 2017

Nov 09, 2017

BUY
$28.96 - $34.0 $26.1 Million - $30.6 Million
901,278
901,278 $30.5 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.